Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H4Cl3IO |
| Molecular Weight | 361.391 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC(Cl)=C(OCC#CI)C=C1Cl
InChI
InChIKey=CTETYYAZBPJBHE-UHFFFAOYSA-N
InChI=1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2
| Molecular Formula | C9H4Cl3IO |
| Molecular Weight | 361.391 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Haloprogin is an active synthetic antifungal and antimonilial agent that was effective in the treatment of superficial fungal and monilial infections of the skin. Because of these two basic therapeutic effects, haloprogin was especially useful in the treatment of infections when the identity of the specific causative organism had not been established or is being determined. Studies in-vitro demonstrated antifungal, antimonilial and antibacterial activity. It was shown to demonstrate marked in-vitro activity against Staphylococcus and Streptococcus. Haloprogin is no longer available in the US.
Originator
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5422306
Curator's Comment: Preliminary data on the antifungal properties of haloprogin, originally identified as M1028, were reported by Seki and associates in 1964.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 4-Phenyl-sulfon-yl-2-(p-tolyl-sulfon-yl)-1H,8H-pyrrolo-[2,3-b]indole. | 2010-10-09 |
|
| (2E)-1-(2-Bromo-phen-yl)-3-(4-meth-oxy-phen-yl)prop-2-en-1-one. | 2010-06-16 |
|
| 2-Amino-4-meth-oxy-6-methyl-pyrimidin-1-ium picrate. | 2010-04-28 |
|
| 5,7-Dimethyl-2,3-dihydro-1H-1,4-diazepin-4-ium picrate. | 2010-04-28 |
|
| Simultaneous spectrophotometric estimation of haloperidol and trihexyphenidyl in tablets. | 2010-03 |
|
| Desipramine hydro-chloride: a non-merohedrally twinned structure. | 2010-02-20 |
|
| 7-(4-Chloro-phen-yl)-9-phenyl-7H-pyrrolo[3,2-e]tetra-zolo[1,5-c]pyrimidine. | 2010-02-13 |
|
| 7-(4-Bromo-phen-yl)-9-phenyl-7H-pyrrolo[3,2-e]tetra-zolo[1,5-c]pyrimidine. | 2010-02-10 |
|
| 6-{[(Benz-yloxy)carbon-yl]-oxy}-2-methyl-hexa-hydro-pyrano[3,2-d][1,3]dioxin-7,8-diyl bis-(chloro-acetate). | 2010-02-10 |
|
| (E)-2-Acetyl-4-[(3-methyl-phenyl-)diazen-yl]phenol: an X-ray and DFT study. | 2010-02-06 |
|
| N,N'-Bis-[(E)-2-fluoro-benzyl-idene]-1-(2-fluoro-phen-yl)methane-diamine. | 2010-01-23 |
|
| 1-(1,3-Benzodioxol-5-yl)ethanone. | 2010-01-16 |
|
| Trimipraminium maleate. | 2010-01-16 |
|
| Dibenzo[b,e]thiepin-11(6H)-one. | 2010-01-13 |
|
| N-(5-Amino-2-methyl-phen-yl)-4-(3-pyri-dyl)-pyrimidin-2-amine. | 2010-01-13 |
|
| Chlorimipraminium picrate. | 2010-01-13 |
|
| 1-(5-Carboxy-pent-yl)-2,3,3-trimethyl-3H-indol-1-ium bromide monohydrate. | 2009-12-16 |
|
| 2,4-Dichloro-1-[1-(2,4-dichloro-benz-yl-oxy)eth-yl]benzene. | 2009-12-16 |
|
| Gabapentin-lactum-chloranilic acid (1/1). | 2009-12-16 |
|
| 11-[3-(Dimethyl-amino)prop-yl]-6,11-dihydro-dibenzo[b,e]thiepin-11-ol. | 2009-12-16 |
|
| 6,11-Dihydro-dibenz[b,e]oxepin-11-one. | 2009-12-16 |
|
| N-(3,4-Dichloro-phen-yl)-3-oxo-butanamide. | 2009-12-04 |
|
| Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag, Norway. | 2009-11-12 |
|
| 2-Bromo-N'-[(2Z)-butan-2-yl-idene]-5-methoxy-benzohydrazide. | 2009-10-31 |
|
| Environmental stresses inhibit splicing in the aquatic fungus Blastocladiella emersonii. | 2009-10-29 |
|
| 1-(2-Methyl-5-nitro-phenyl)guanidinium picrate. | 2009-10-17 |
|
| (E)-3-[(3-Bromo-phen-yl)imino-meth-yl]benzene-1,2-diol: a combined X-ray and computational structural study. | 2009-09-09 |
|
| 3-(2-Chloro-ethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one. | 2009-07-25 |
|
| A second polymorph of (2E)-1-(4-fluoro-phen-yl)-3-(3,4,5-trimethoxy-phen-yl)prop-2-en-1-one. | 2009-07-25 |
|
| 2-Amino-5-nitro-phenyl 2-chloro-phenyl ketone. | 2009-07-18 |
|
| Propiverinium picrate. | 2009-07-01 |
|
| (E)-2-{(2-Hydroxy-naphthalen-1-yl)methyl-ene}hydrazinecarboxamide. | 2009-04-25 |
|
| (E)-2-[(2-Hydr-oxy-5-nitro-phen-yl)iminiometh-yl]phenolate. | 2009-02-11 |
|
| 3-(2,6-Dioxopiperidin-3-yl)-3-aza-bicyclo-[3.2.0]heptane-2,4-dione. | 2009-01-28 |
|
| (E)-2-[(2-Hydr-oxy-5-nitro-phen-yl)iminiometh-yl]-4-nitro-phenolate. | 2009-01-14 |
|
| Synthesis and microbiological activity of some N-(o-hydroxyphenyl)benzamides and phenylacetamides as the possible metabolites of antimicrobial active benzoxazoles: part II. | 2001-02-24 |
|
| Synthesis and microbiological activity of some novel 5- or 6-methyl-2-(2,4-disubstituted phenyl) benzoxazole derivatives. | 1998-05-30 |
|
| Synthesis and quantitative structure-activity relationship analysis of N-triiodoallyl- and N-iodopropargylazoles. New antifungal agents. | 1987-03 |
|
| In vitro activity of ME1401, a new antifungal agent. | 1986-11 |
|
| Haloprogin: mode of action studies in Candida albicans. | 1974-09 |
|
| Haloprogin: a topical antifungal agent. | 1970-05 |
Sample Use Guides
1% cream or solution applied liberally to the affected area twice daily
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5422306
The in vitro fungistatic concentrations were determined by a serial dilution method using Sabouraud's liquid medium. The concentration of drug tested ranged from 0.19 to 100 ug/ml. All tubes were inoculated with approximately 10(5) viable macrospores obtained by washing the surface of a 14-day slant culture of the test dermatophyte with Sabouraud's liquid medium and diluting to the desired concentration. The inoculated assay tubes were incubated at room temperature (28 Celsius) for 7 days and examined for visible growth.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:07:36 GMT 2025
by
admin
on
Wed Apr 02 07:07:36 GMT 2025
|
| Record UNII |
AIU7053OWL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C514
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
||
|
WHO-ATC |
D01AE11
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
||
|
CFR |
21 CFR 333.210
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
||
|
WHO-VATC |
QD01AE11
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1355
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
m1184
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
C65842
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
100071
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
DB00793
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
2263
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
3561
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
212-286-6
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
26422
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | RxNorm | ||
|
AIU7053OWL
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
DTXSID9046865
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
C100276
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
SUB08008MIG
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL1289
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
HALOPROGIN
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
777-11-7
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY | |||
|
100000083926
Created by
admin on Wed Apr 02 07:07:36 GMT 2025 , Edited by admin on Wed Apr 02 07:07:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |